Abstract
High-grade endometrial stromal sarcoma (HG-ESS) is a malignant uterine tumour with a poor prognosis. This study aimed to demonstrate the usefulness of maintenance chemotherapy with paclitaxel (PTX) and carboplatin (CBDCA) for HG-ESS recurrence, by examining a case of HG-ESS tumour progression as a result of maintenance therapy interruption because of the COVID-19 pandemic. The patient was a woman in her 60s who presented with lower abdominal pain, nausea and a pelvic tumour, which was diagnosed as HG-ESS. Chemotherapy with PTX (175 mg/m2 day 1) + CBDCA (area under the concentration-time curve 5 day 1) every 21–28 days (TC therapy) was administered for long-term maintenance of HG-ESS. After 26 cycles, chemotherapy had to be postponed because of the COVID-19 pandemic, thus leading to disease progression and eventually death. In conclusion, TC therapy can prolong survival in patients with HG-ESS, and maintenance chemotherapy should not be postponed.
Reference22 articles.
1. Anti-cancer therapy and clinical trial considerations for gynecologic oncology patients during the COVID-19 pandemic crisis;Pothuri;Gynecol Oncol,2020
2. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
3. Effect of social contagion on health behaviour for year t+1. HBt NBn is the health behaviour of the nth neighbour. Available: https://jsgo.or.jp/guideline/taigan/ijco2013_Chapter7.pdf [Accessed 29 Mar 2022].
4. Uterine neoplasms. Available: https://www2.tri-kobe.org/nccn/guideline/gynecological/english/uterine.pdf [Accessed 29 Mar 2022].
5. Effective treatment of a patient with a high-grade endometrial stromal sarcoma with an accelerated regimen of carboplatin and paclitaxel;Szlosarek;Anticancer Drugs,2000
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Multiple drugs;Reactions Weekly;2022-10-29